BW
ARKG icon

Bison Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bison Wealth’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-444
Closed -$27K – 366
2021
Q4 		$27K Sell
444
-278
-39% -$19.2K 0.02% 273
2021
Q3 		$54K Hold
722
– – 0.02% 309
2021
Q2 		$67K Sell
722
-400
-36% -$34K 0.03% 302
2021
Q1 		$100K Buy
1,122
+444
+65% +$44K 0.04% 277
2020
Q4 		$63K Hold
678
– – 0.03% 285
2020
Q3 		$43K Buy
678
+400
+144% +$23.4K 0.03% 255
2020
Q2 		$15K Buy
+278
New +$11.9K 0.01% 295
2020
Q1 		– Sell
-700
Closed -$23K – 334
2019
Q4 		$23K Buy
+700
New +$22.2K 0.01% 324

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bison Wealth's ARKG Position: Q1 2022 in Review

Bison Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 444 shares — an estimated $27K sold.

Bison Wealth first reported a position in ARKG in Q4 2019 and held it in 8 quarters. The position peaked at $100K in Q1 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Bison Wealth reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Bison Wealth sold 444 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $27K.
  • Bison Wealth first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 8 quarters.
  • Bison Wealth's ARK Genomic Revolution ETF position peaked at $100K in Q1 2021.
  • 387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Bison Wealth's 13F filing for Q1 2022, filed 12 May 2022.